Kevin J. Curran, MD
Pediatric Hematologist-Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Cellular Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Pediatric Leukemia
Request an Appointment
About Me
- Associate Attending Pediatrician
I am a physician on the MSK Kids team who specializes in cellular therapy as a member of the Pediatric Stem Cell Transplantation and Cellular Therapies Service. I treat children and young adults with blood cancers such as leukemia, disorders of the bone marrow that hamper the ability to make normal blood cells, and immune system problems that impair the body’s ability to fight infection.
In addition to caring for patients, I am Pediatric Director of the Cellular Therapeutic Center at Memorial Sloan Kettering. In this capacity, my colleagues and I develop novel cellular treatments for children and young adults with leukemia and lymphoma that do not respond to standard therapies. Specifically, we used chimeric antigen receptor (CAR) T cells to recognize and kill cancer cells.
Read more
This promising form of cellular therapy is currently being assessed in clinical trials at MSK Kids for children and adults with both blood cancers and solid tumors. The ultimate goal of cellular therapies is to provide more effective treatment options for all patients with cancer and avoid the long-term side effects that we observe in survivors of childhood cancers who received conventional anticancer treatments.
When I meet with a new patient and family, I speak with them to understand what kind of care they have already received and their personal goals for treatment. The families I care for are going through what is likely the most intense period of their lives. My goal is to get them back to their normal lives through more effective and less toxic therapies. I am most gratified when I see children I have treated resume their regular lives, going back to school, camp, or family vacations. I achieve this by working in collaboration with my colleagues at MSK Kids, who are all equally dedicated to caring for the whole patient and their family.
A pediatric hematologist-oncologist is a doctor who treats cancers of the blood in children and adolescents. This doctor is a hematologist (HEE-muh-TAH-loh-jist) who diagnoses and treats blood disorders. They also are an oncologist (cancer doctor).
My Specialties
- Cellular Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Pediatric Leukemia
Education
- MD, Georgetown University
Residencies
- Pediatrics - Tufts-New England Medical Center
Fellowships
- Pediatric Hematology/Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- General Pediatrics
- Pediatric Hematology/Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Curran sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Curran
- A Phase I Study of UCART22 CAR T-Cell Therapy in Children and Young Adults with Recurrent or Persistent B-Cell Acute Lymphoblastic Leukemia
- A Phase II Study Assessing a Second Infusion of Tisagenlecleucel CAR T-Cell Therapy in Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia
- Clinical Trials Co-Investigated by Dr. Curran
- A Phase 1 Study of CD371-Targeting CAR T Cell Therapy in People With Acute Myeloid Leukemia
- A Phase 1 Study of LN-145 and LN-144 in Children, Adolescents, and Young Adults With Solid Tumors
Read more
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Patient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Kevin J. Curran discloses the following relationships and financial interests:
-
Atara Biotherapeutics
Professional Services and Activities -
Canaccord Genuity Inc.
Professional Services and Activities -
Gerson Lehrman Group
Professional Services and Activities -
Guidepoint Global Advisors
Professional Services and Activities
-
Momentum Acquisitions
Professional Services and Activities -
Novartis
Professional Services and Activities -
Turn Biotechnologies, Inc.
Equity; Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].